| Protein category: |
Recombinant protein |
| Source: |
proteins, Recombinants or rec |
| Target: |
EnDdoglin / CD105 / ENG Protein |
| Conjugation: |
histidine |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Group: |
recombinants |
| Gene target: |
Endoglin / CD105 / ENG Protein (His Tag) |
| Short name: |
Recombinant Endoglin / CD105 / ENG Protein (His Tag) |
| Technique: |
E, Tags, adv advises they will be reconstituted in a buffer soluion or culture medium for cell culture, coli recombinant proteins are , supplied as white sterile powder lyopillized, Recombinant, genetic recombinations , in Escherichia coli |
| Label: |
His |
| Species: |
Humans, Human |
| Alternative name: |
sapiens Endoglin / CD105 / endoglin Protein (histidine detection labelled), recombinant H |
| Alternative technique: |
rec |
| Alternative to gene target: |
DNA-templated and biological process this GO :0007155 and cell adhesion and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007507 and heart development and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0009986 and cell surface and cellular component this GO :0010628 and positive regulation of gene expression and biological process this GO :0010862 and positive regulation of pathway-restricted SMAD protein phosphorylation and biological process this GO :0016477 and cell migration and biological process this GO :0017015 and regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0022009 and central nervous system vasculogenesis and biological process this GO :0022617 and extracellular matrix disassembly and biological process this GO :0030155 and regulation of cell adhesion and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0030509 and BMP signaling pathway and biological process this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030513 and positive regulation of BMP signaling pathway and biological process this GO :0031953 and negative regulation of protein autophosphorylation and biological process this GO :0031960 and response to corticosteroid and biological process this GO :0032967 and positive regulation of collagen biosynthetic process and biological process this GO :0034713 and type I transforming growth factor beta receptor binding and molecular function this GO :0035556 and intracellular signal transduction and biological process this GO :0036273 and response to statin and biological process this GO :0042060 and wound healing and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042325 and regulation of phosphorylation and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048185 and activin binding and molecular function this GO :0048745 and smooth muscle tissue development and biological process this GO :0048844 and artery morphogenesis and biological process this GO :0048845 and venous blood vessel morphogenesis and biological process this GO :0048870 and cell motility and biological process this GO :0050431 and transforming growth factor beta binding and molecular function this GO :0051001 and negative regulation of nitric-oxide synthase activity and biological process this GO :0060326 and cell chemotaxis and biological process this GO :0060348 and bone development and biological process this GO :0060394 and negative regulation of pathway-restricted SMAD protein phosphorylation and biological process this GO :0070022 and transforming growth factor beta receptor homodimeric complex and cellular component this GO :0070278 and extracellular matrix constituent secretion and biological process this GO :0070483 and detection of hypoxia and biological process this GO :0071260 and cellular response to mechanical stimulus and biological process this GO :0071559 and response to transforming growth factor beta and biological process this GO :0072563 and endothelial microparticle and cellular component, END and HHT1 and ORW1, ENG and IDBG-639059 and ENSBTAG00000008997 and 615844, ENG and IDBG-86582 and ENSG00000106991 and 2022, Eng and IDBG-160783 and ENSMUSG00000026814 and 13805, cytoplasmic mediator activity, cytoplasmic mediator activity and also this GO :0005114 : type II transforming growth factor beta receptor binding and also this GO :0005515 : protein binding and also this GO :0005534 : galactose binding and also this GO :0005539 : glycosaminoglycan binding and also this GO :0034713 : type I transforming growth factor beta receptor binding and also this GO :0042803 : protein homodimerization activity and also this GO :0048185 : activin binding and also this GO :0050431 : transforming growth factor beta binding, cytoplasmic mediator activity and molecular function this GO :0005114 and type II transforming growth factor beta receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005534 and galactose binding and molecular function this GO :0005539 and glycosaminoglycan binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006355 and regulation of transcription, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001300 and chronological cell aging and biological process this GO :0001525 and angiogenesis and biological process this GO :0001569 and patterning of blood vessels and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001666 and response to hypoxia and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0001937 and negative regulation of endothelial cell proliferation and biological process this GO :0001947 and heart looping and biological process this GO :0003084 and positive regulation of systemic arterial blood pressure and biological process this GO :0003273 and cell migration involved in endocardial cushion formation and biological process this GO :0004888 and transmembrane signaling receptor activity and molecular function this GO :0005024 and transforming growth factor beta-activated receptor activity and molecular function this GO :0005072 and transforming growth factor beta receptor, this GO :0004888 : transmembrane signaling receptor activity, this GO :0004888 : transmembrane signaling receptor activity and also this GO :0005024 : transforming growth factor beta-activated receptor activity and also this GO :0005072 : transforming growth factor beta receptor, this GO :0005024 : transforming growth factor beta-activated receptor activity, this GO :0005072 : transforming growth factor beta receptor, this GO :0005114 : type II transforming growth factor beta receptor binding, this GO :0005515 : protein binding, this GO :0005534 : galactose binding, this GO :0005539 : glycosaminoglycan binding, this GO :0034713 : type I transforming growth factor beta receptor binding, this GO :0042803 : protein homodimerization activity, this GO :0048185 : activin binding, this GO :0050431 : transforming growth factor beta binding, transforming growth factor beta receptor, endoglin |
| Identity: |
3349 |
| Gene: |
ENG |
More about : ENG |
| Long gene name: |
endoglin |
| Synonyms gene: |
ORW1 ORW |
| Synonyms gene name: |
Osler-Rendu-Weber syndrome 1 |
| Synonyms: |
END HHT1 CD105 |
| Locus: |
9q34, 11 |
| Discovery year: |
1993-03-03 |
| GenBank acession: |
AF035753 |
| Entrez gene record: |
2022 |
| Pubmed identfication: |
8404038 10548503 |
| Classification: |
CD molecules |
| Havana BLAST/BLAT: |
OTTHUMG00000020723 |
| Locus Specific Databases: |
Hereditary Hemorrhagic Telangiectasia (HHT) Mutation Database LRG_589 |